Sevelamer hydrochloride reverses parathyroid gland enlargement via regression of cell hypertrophy but not apoptosis in rats with chronic renal insufficiency

Nephrology Dialysis Transplantation

Volumn 21, Issue 3, 2006, Pages 634-643

  Nagano, Nobuo ^a   Miyata, Sonoe ^a   Abe, Megumi ^a   Wakita, Sachiko ^a   Kobayashi, Nami ^a   Wada, Michihito ^a  

^a KIRIN BREWERY CO LTD   (Japan)

Author keywords

Cell hypertrophy; Parathyroid gland hyperplasia; Parathyroid hormone (PTH); Phosphorus; Sevelamer hydrochloride

Indexed keywords

ADENINE; CALCIUM; CREATININE; NITROGEN; PARATHYROID HORMONE; PHOSPHORUS; SEVELAMER; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CALCIUM BLOOD LEVEL; CELL COUNT; CELL VOLUME; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIETARY INTAKE; DISEASE SEVERITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HYPERPLASIA; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UREA NITROGEN BLOOD LEVEL;

ANIMALS; APOPTOSIS; CALCIUM; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; HYPERPLASIA; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE, CHRONIC; MALE; ORGAN SIZE; PARATHYROID GLANDS; PARATHYROID HORMONE; PHOSPHORUS; POLYAMINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33644857657     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi137     Document Type: Article

References (20)

1. Drüeke TB. Cell biology of parathyroid gland hyperplasia in chronic renal failure. J Am Soc Nephrol 2000; 11: 1141-1152
2. Parfitt AM. The hyperparathyroidism of chronic renal failure: A disorder of growth. Kidney Int 1997; 52: 3-9
3. Fukagawa M. Cell biology of parathyroid hyperplasia in uremia. Am J Med Sci 1999; 317: 377-382
4. Slatopolsky E, Dusso A, Brown AJ. The role of phosphorus in the development of secondary hyperparathyroidism and parathyroid cell proliferation in chronic renal failure. Am J Med Sci 1999; 317: 370-376
5. Silver J, Kilav R, Naveh-Many T. Mechanisms of secondary hyperparathyroidism. Am J Physiol Renal Physiol 2002; 283: F367-F376
6. Amin N. The impact of improved phosphorus control: Use of sevelamer hydrochloride in patients with chronic renal failure. Nephrol Dial Transplant 2002; 17: 340-345
7. Nagano N, Miyata S, Onaba S et al. Sevelamer hydrochloride (Renagel®), a non-calcaemic phosphate binder, arrests parathyroid gland hyperplasia in rats with progressive chronic renal insufficiency. Nephrol Dial Transplant 2001; 16: 1870-1878
8. Nagano N, Miyata S, Obana S et al. Sevelamer hydrochloride, a calcium-free phosphate binder, inhibits parathyroid cell proliferation in partially nephrectomized rats. Nephrol Dial Transplant 2003; 18 [Suppl. 3]: 81-85
9. Yokozawa T, Zheng PD, Oura H et al. Animal model of adenine-induced chronic renal failure in rats. Nephron 1986; 44: 230-234
10. Katsumata K, Kusano K, Hirata M et al. Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats. Kidney Int 2003; 64: 441-450
11. Loghman-Adham M. Role of phosphate retention in the progression of renal failure. J Lab Clin Med 1993; 122: 16-26
12. Nagano N, Miyata S, Obana S et al. Sevelamer hydrochloride, a phosphate binder, protects against deterioration of renal function in rats with progressive chronic renal insufficiency. Nephrol Dial Transplant 2003; 18: 2014-2023
13. Wada M, Furuya Y, Sakiyama J et al. The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency: Control of parathyroid cell growth via a calcium receptor. J Clin Invest 1997; 100: 2977-2983
14. Wada M, Nagano N, Furuya et al. Calcimimetic NPS R-568 prevents parathyroid hyperplasia in rats with severe secondary hyperparathyroidism. Kidney Int 2000; 57: 50-58
15. Wang Q, Paloyan E, Parfitt AM. Phosphate administration increases both size and number of parathyroid cells in adult rats. Calcif Tissue Int 1996; 58: 40-44
16. Wang Q, Palnitkar S, Parfitt AM. Parathyroid cell proliferation in the rat: Effect of age and of phosphate administration and recovery. Endocrinology 1996; 137: 4558-4562
17. Cinti S, Sbarbati A. Ultrastrucure of human parathyroid cells in health and disease. Microsc Res Tech 1995; 32: 164-179
18. Wernerson A, Svensson O, Reinholt FP. Quantitative and three-dimensional aspects of the rat parathyroid gland in normo-, hypo-, and hypercalcemia. Microsc Res Tech 1995; 32: 129-147
19. Nagano N, Obana S, Miyata S et al. Mechanism of the cholesterol-lowering effect of sevelamer hydrochloride, a novel phosphate binder. J Jpn Soc Dial Ther 2003; 36: 47-54
20. Ritter CS, Martin DR, Lu Y et al. Reversal of secondary hyperparathyroidism by phosphate restriction restores parathyroid calcium-sensing receptor expression and function. J Bone Miner Res 2002; 17: 2206-2213